Editorial for “Radiomics Nomogram Based on Dual‐Sequence MRI for Assessing Ki‐67 Expression in Breast Cancer”
Journal of Magnetic Resonance Imaging · 2024
DOI: 10.1002/jmri.29180 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Magnetic Resonance Imaging, 2024. Verfasst von Ravikanth Balaji und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Nuclear Medicine, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), SQU Street, Al Khoud, MUSCAT, SU…. Hauptthemen laut MEDLINE: Breast Neoplasms, Magnetic Resonance Imaging, Ki-67 Antigen, Nomograms. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiology and Nuclear Medicine, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), SQU Street, Al Khoud, MUSCAT, SULTANATE OF OMAN.
ORCID-Profile: Ravikanth Balaji
Zitieren
APA
Balaji, R., & Al Sukaiti, R. (2024). Editorial for “Radiomics Nomogram Based on Dual‐Sequence MRI for Assessing Ki‐67 Expression in Breast Cancer”. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.29180
Vancouver
Balaji R, Al Sukaiti R. Editorial for “Radiomics Nomogram Based on Dual‐Sequence MRI for Assessing Ki‐67 Expression in Breast Cancer”. Journal of Magnetic Resonance Imaging. 2024. doi:10.1002/jmri.29180
BibTeX
@article{Balaji2024,
author = {Balaji, Ravikanth and Al Sukaiti, Rashid},
title = {Editorial for “Radiomics Nomogram Based on Dual‐Sequence MRI for Assessing Ki‐67 Expression in Breast Cancer”},
journal = {Journal of Magnetic Resonance Imaging},
year = {2024},
doi = {10.1002/jmri.29180}
}
EUVIMED